Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 512047, 5 pages
http://dx.doi.org/10.1100/2012/512047
Clinical Study

Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia

1Newham Centre for Mental Health, East London NHS Foundation Trust and University of Essex, London E13 8SP, UK
2Buckinghamshire NHS Primary Care Trust, Community Pharmacy, Aylesbury HP19 8ET, UK
3North East London NHS Foundation Trust, General Adult Psychiatry, Ilford, Essex IG3 8XJ, UK
4Kent and Medway NHS and Social Care Partnership Trust, Kent ME19 4AX, UK

Received 25 October 2011; Accepted 7 December 2011

Academic Editor: Serdar Murat Dursun

Copyright © 2012 Frank Röhricht et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Kerwin and A. Bolonna, “Management of Clozapine-resistant schizophrenia,” Advances in Psychiatric Treatment, vol. 11, no. 2, pp. 101–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. R. Conley and R. W. Buchanan, “Evaluation of treatment-resistant schizophrenia,” Schizophrenia Bulletin, vol. 23, no. 4, pp. 663–674, 1997. View at Google Scholar · View at Scopus
  3. National Institute for Clinical Excellence, http://www.nice.org.uk.
  4. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer, “Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with Chlorpromazine,” Archives of General Psychiatry, vol. 45, no. 9, pp. 789–796, 1988. View at Google Scholar · View at Scopus
  5. K. Wahlbeck, M. Cheine, A. Essali, and C. Adams, “Evidence of Clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials,” American Journal of Psychiatry, vol. 156, no. 7, pp. 990–999, 1999. View at Google Scholar · View at Scopus
  6. Sandoz. Summary of Product Characteristics.
  7. F. A. Wiesel, L. Farde, and C. Halldin, “Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET,” Acta Psychiatrica Scandinavica, Supplement, vol. 80, no. 352, pp. 30–34, 1989. View at Google Scholar · View at Scopus
  8. W. V. Bobo, K. Jayathilake, M. A. Lee, and H. Y. Meltzer, “Melperone, an atypical antipsychotic drug with Clozapine-like effect on plasma prolactin: contrast with typical neuroleptics,” Human Psychopharmacology, vol. 24, no. 5, pp. 415–422, 2009. View at Publisher · View at Google Scholar · View at PubMed
  9. L. Barbato, A. Monge, F. Stocchi, and G. Nordera, “Melperone in the treatment of iatrogenic psychosis in Parkinson's disease,” Functional Neurology, vol. 11, no. 4, pp. 201–207, 1996. View at Google Scholar · View at Scopus
  10. W. V. Bobo, K. Jayathilake, M. A. Lee, and H. Y. Meltzer, “Changes in weight and body mass index during treatment with melperone, Clozapine and typical neuroleptics,” Psychiatry Research, vol. 176, no. 2-3, pp. 114–119, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. S. Stein, A. Schmoldt, and M. Schulz, “Fatal intoxication with melperone,” Forensic Science International, vol. 113, no. 1–3, pp. 409–413, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Bjerkenstedt, “Melperone in the treatment of schizophrenia,” Acta Psychiatrica Scandinavica, Supplement, vol. 80, no. 352, pp. 35–39, 1989. View at Google Scholar
  13. H. Y. Meltzer, T. Sumiyoshi, and K. Jayathilake, “Melperone in the treatment of neuroleptic-resistant schizophrenia,” Psychiatry Research, vol. 105, no. 3, pp. 201–209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ventura, D. Lukoff, K. H. Nuechterlein et al., “Appendix 1: Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0) scales, anchor points and administration manual,” International Journal of Methods in Psychiatric Research, vol. 3, pp. 227–243, 1993. View at Google Scholar
  15. T. Sumiyoshi, K. Jayathilake, and H. Y. Meltzer, “A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia,” Schizophrenia Research, vol. 62, no. 1-2, pp. 65–72, 2003. View at Publisher · View at Google Scholar · View at Scopus